Stay updated on Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T22:20:08.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” in agency content. It does not change the clinical trial information.
    Difference
    1%
    Check dated 2026-10-24T22:23:28.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer shows a newer site revision number, changing from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:19:25.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:12:35.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual content and indicating the resource is restricted.
    Difference
    19%
    Check dated 2026-09-19T22:27:14.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added the NIH funding identifier '2019 ( U.S. NIH Grant/Contract )' to the study's identifiers and updated the page revision from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T19:34:43.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.